monday.com(US:MNDY) Investors·2026-02-09 21:42Group 1 - Major stock indexes, including Dow Jones and S&P 500, experienced a decline of 0.2% as Wall Street awaited the rescheduled January jobs report [1] - Monday.com, an artificial intelligence stock, reported a disappointing full-year outlook, leading to a significant drop in its shares despite beating Q4 estimates [1][1] - The overall sentiment in the market is cautious as investors are closely monitoring upcoming economic data [1] Group 2 - Hims & Hers halted its Wegovy knockoff after just two days, indicating potential regulatory challenges from the FDA [1] - Novo Nordisk's stock faced a two-day plunge as the CFO acknowledged "extraordinary challenges" for 2026, reflecting concerns about the company's future performance [1] - Eli Lilly is highlighted as a strong stock performer amid increasing competition with Novo Nordisk, suggesting a shift in market dynamics within the biotech sector [1]